391 related articles for article (PubMed ID: 15841787)
1. Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden.
Roussos L; Ekström U; Ehle PN; Oqvist B; Floren CH
Scand J Urol Nephrol; 2004; 38(6):504-10. PubMed ID: 15841787
[TBL] [Abstract][Full Text] [Related]
2. Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus.
Ha SK; Park HS; Kim KW; Kim SJ; Kim DH; Kim JH; Lee HY; Han DS
Nephrol Dial Transplant; 1999 Sep; 14(9):2144-9. PubMed ID: 10489223
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients.
Atageldiyeva KK; Nemr R; Echtay A; Racoubian E; Sarray S; Almawi WY
Gene; 2019 Oct; 715():144011. PubMed ID: 31357022
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genotype and plasma lipid levels in Caucasian diabetic patients.
Morbois-Trabut L; Chabrolle C; Garrigue MA; Lasfargues G; Lecomte P
Diabetes Metab; 2006 Jun; 32(3):270-5. PubMed ID: 16799405
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study on the influence of apolipoprotein e and serum lipids in progressive renal failure.
Roussos L; Ehle PN; Florén CH
Int Urol Nephrol; 2005; 37(2):329-34. PubMed ID: 16142566
[TBL] [Abstract][Full Text] [Related]
6. [Polymorphisms Ser447Ter of lipoprotein-lipase gene, Cys112Arg and Arg158Cys of apolipoprotein E gene in patients with obesity].
Kirillova OO; Vorozhko IV; Gapparova KM; Chekhonina IuG; Sentsova TB; Tutel'ian VA
Vopr Pitan; 2013; 82(4):4-9. PubMed ID: 24340925
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E gene polymorphisms and risk for coronary artery disease in Chinese Xinjiang Uygur and Han population.
Yang SL; He BX; Liu HL; He ZY; Zhang H; Luo JP; Hong XF; Zou YC
Chin Med Sci J; 2004 Jun; 19(2):150-4. PubMed ID: 15250257
[TBL] [Abstract][Full Text] [Related]
8. [Apolipoprotein E polymorphism in a Moroccan population: allele frequency and relation to plasma lipid concentrations].
Lahlali-Kacemi N; Bamou Y; Guedira A; Hassani M; Visvikis S; Siest G; Alami N; Kabbaj O; Lahrichi M
Ann Biol Clin (Paris); 2002; 60(1):73-8. PubMed ID: 11830396
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus.
Horita K; Eto M; Makino I
Atherosclerosis; 1994 Jun; 107(2):203-11. PubMed ID: 7980694
[TBL] [Abstract][Full Text] [Related]
10. Increased prevalence of apolipoprotein E3/E4 genotype among Swedish renal transplant recipients.
Roussos L; Flor n C; Carlson J; Svensson PJ; Wallmark A; Ekberg H
Nephron; 1999 Sep; 83(1):25-30. PubMed ID: 10461032
[TBL] [Abstract][Full Text] [Related]
11. Association between the apolipoprotein E polymorphism and arterial wall thickness in asymptomatic adults.
Hanon O; Girerd X; Luong V; Jeunemaitre X; Laurent S; Safar ME
J Hypertens; 2000 Apr; 18(4):431-6. PubMed ID: 10779094
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E polymorphism in diabetic and non-diabetic patients: does it really contribute to atherosclerosis?
Camsari A; Tamer L; Aras Ateş N; Pekdemir H; Ciçek D; Ercan B; Camdeviren H; Atik U
Acta Cardiol; 2005 Aug; 60(4):409-14. PubMed ID: 16128374
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.
Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M
Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
[TBL] [Abstract][Full Text] [Related]
15. Obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin.
Marques-Vidal P; Bongard V; Ruidavets JB; Fauvel J; Hanaire-Broutin H; Perret B; Ferrières J
Obes Res; 2003 Oct; 11(10):1200-6. PubMed ID: 14569045
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E gene polymorphism in the Mongolian population.
Svobodová H; Kucera F; Stulc T; Vrablík M; Amartuvshin B; Altannavch Ts; Ceska R
Folia Biol (Praha); 2007; 53(4):138-42. PubMed ID: 17706019
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters.
Jemaa R; Elasmi M; Naouali C; Feki M; Kallel A; Souissi M; Sanhaji H; Hadj Taïeb S; Souheil O; Kaabachi N
Clin Biochem; 2006 Aug; 39(8):816-20. PubMed ID: 16714010
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
Duman BS; Oztürk M; Yilmazer S; Hatemi H
Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
[TBL] [Abstract][Full Text] [Related]
19. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects.
Vauhkonen I; Niskanen L; Ryynänen M; Voutilainen R; Partanen J; Töyry J; Mercuri M; Rauramaa R; Uusitupa M
Diabet Med; 1997 Sep; 14(9):748-56. PubMed ID: 9300224
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E gene polymorphism alters lipids before pancreas transplantation.
Balakrishnan S; Colling C; Burkman T; Erickson J; Lyden E; Maheshwari H; Mack-Shipman L; Lane J; Larsen J
Transplantation; 2002 Oct; 74(7):974-7. PubMed ID: 12394840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
